Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Hauser

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Open Forum Infectious Diseases|September 2, 2025
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream InfectionsDariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2020
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-IbDavid A Butler, Amisha P Rana, Fiorella Krapp, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A novel mechanism of ceftolozane-tazobactam resistance in <i>Pseudomonas aeruginosa</i> mediated by L2 β-lactamasePreeti Garai, Sophia H Nozick, Caroline C Jozefczyk, et al.
The Journal of Biological Chemistry|December 16, 2014
A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipasesGregory H Tyson, Andrei S Halavaty, Hyunjin Kim, et al.
Open Forum Infectious Diseases|November 28, 2025
Impact of Remote Cholecystectomy on Clinical Outcomes Following <i>Pseudomonas aeruginosa</i> Bloodstream InfectionHanna K Bertucci, Lyndsey R Heise, Anne Kurze, et al.
Plos One|November 21, 2012
Structure of the type III secretion effector protein ExoU in complex with its chaperone SpcUAndrei S Halavaty, Dominika Borek, Gregory H Tyson, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa InfectionBryan J Berube, Katherine R Murphy, Matthew C Torhan, et al.
Msystems|December 22, 2023
Phenotypes of a <i>Pseudomonas aeruginosa</i> hypermutator lineage that emerged during prolonged mechanical ventilation in a patient without cystic fibrosisSophia H Nozick, Egon A Ozer, Rachel Medernach, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
<i>Pseudomonas aeruginosa</i> population dynamics in a vancomycin-induced murine model of gastrointestinal carriageMarine Lebrun-Corbin, Bettina H Cheung, Karthik Hullahalli, et al.
The EMBO Journal|January 20, 2007
Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesisChristian Ottmann, Lubna Yasmin, Michael Weyand, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Open Forum Infectious Diseases|September 2, 2025
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream InfectionsDariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2020
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-IbDavid A Butler, Amisha P Rana, Fiorella Krapp, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A novel mechanism of ceftolozane-tazobactam resistance in <i>Pseudomonas aeruginosa</i> mediated by L2 β-lactamasePreeti Garai, Sophia H Nozick, Caroline C Jozefczyk, et al.
The Journal of Biological Chemistry|December 16, 2014
A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipasesGregory H Tyson, Andrei S Halavaty, Hyunjin Kim, et al.
Open Forum Infectious Diseases|November 28, 2025
Impact of Remote Cholecystectomy on Clinical Outcomes Following <i>Pseudomonas aeruginosa</i> Bloodstream InfectionHanna K Bertucci, Lyndsey R Heise, Anne Kurze, et al.
Plos One|November 21, 2012
Structure of the type III secretion effector protein ExoU in complex with its chaperone SpcUAndrei S Halavaty, Dominika Borek, Gregory H Tyson, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa InfectionBryan J Berube, Katherine R Murphy, Matthew C Torhan, et al.
Msystems|December 22, 2023
Phenotypes of a <i>Pseudomonas aeruginosa</i> hypermutator lineage that emerged during prolonged mechanical ventilation in a patient without cystic fibrosisSophia H Nozick, Egon A Ozer, Rachel Medernach, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
<i>Pseudomonas aeruginosa</i> population dynamics in a vancomycin-induced murine model of gastrointestinal carriageMarine Lebrun-Corbin, Bettina H Cheung, Karthik Hullahalli, et al.
The EMBO Journal|January 20, 2007
Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesisChristian Ottmann, Lubna Yasmin, Michael Weyand, et al.
Pageof 13